tracking the spread of COVID-19

The news of Coronavirus skyrocketing in China peaked during the month of January. At this time, the virus seemed so far away from our reality. Quickly, the virus has spread across the world. The testing for COVID-19 has become more advanced by the week and every day we see hundreds if not thousands more confirmed cases. Track the spread of COVID-19 here.

What can we do to prevent the spread of COVID-19?

As a healthy young individual, the most effective thing you can do is stay home and prevent the spread of this potentially deadly virus. Each citizen plays a large role in spreading the virus to others. The American population who are elderly or immunocompromised are at a higher risk for developing symptoms of the COVID-19 virus. Because of this, ALL citizens are at risk of spreading the virus and should take the quarantine seriously.

The CDC’s guidelines for how to prevent the spread of COVID-19 are conservative at this point. Wash your hands frequently and stay away from densely populated areas. This includes restaurants, bars, and stores. To bolster the prevention of the virus, counties in the San Francisco Bay area have placed a “shelter in place” order. Preventative measures like this will likely spread to other large cities in the coming days.

An important resource to note is the CDC’s guidelines for assessing risk in citizens that have potential exposure to the virus. Be sure to know the signs and symptoms of the virus and utilize any local drive-thru testing centers. Many hospitals are allowing at-risk citizens to call their hotline for remote screening of COVID-19. It’s important for citizens to stay up-to-date on recent news and be prepared to stay home in the coming weeks. As the spread of COVID-19 continues to ramp up in the US, it will be important that everyone does their part.

Work from home, avoid crowded areas, and prepare to stay home for at least the next three weeks. Preventing this virus starts with each individual making a choice to change their lifestyle for the better of their communities. The reason that China was able to reduce the spreading of COVID-19 is because they were willing to effectively quarantine.

How can we track the spread of COVID-19 more effectively?

Testing in the United States is slowly climbing. But, because of limited testing kits across the country, hospitals are being sure to utilize tests on only higher-risk citizens. As of now, people who have not been in direct contact with a confirmed case of Coronavirus are considered low-risk. However, citizens living in densely populated areas with high contact should assume that they have been exposed to the virus. Even if they are not tested, low-risk citizens should take all the same precautions as high-risk individuals to decrease the spread of COVID-19.

Digital healthcare technologies have been integral in tracking COVID-19. Here is how some tech companies are helping to control the spread of the virus. cliexa has incorporated the CDC’s risk assessment guidelines into a platform that can compile data and assess the risk of each patient that is worried about their exposure. This platform provides patient-reported data on risk and symptoms to physicians. This helps healthcare professionals better manage the amount of exposure cases across the nation. We are offering free demos of this platform. You can visit our contact page to schedule a time with our team to learn about the COVID-19 screening application offered through the cliexa platform.

 

In 2018, cliexa was selected as one of Jumpstart Foundry’s portfolio companies. Jumpstart recognizes the value of recent healthcare industry trends including “Remote Patient Monitoring” and “Telehealth.” In their recent article, JSF featured cliexa in their discussion of these recent technological trends in healthcare.

One of the key challenges in healthcare that we are solving is being able to render results interpretable to patients and providers, while creating efficient, streamlined communication and workflow. cliexa’s Remote Monitoring platforms assist providers in making more informed decisions about treatment plans and enable them to respond more quickly to new data so their patients will have fewer complications or side effects. cliexa suite of products enables providers to deliver value-based care which translates to significant cost savings.

With clinically validated scoring models, our platform provides clinicians multiple reference points with correlations to identify the accuracy of patient reported data which will result in better patient and clinician experience and enables more responsive and preventive treatments.

Patients will play a greater role in their care with cliexa and will be able to make valuable correlations to causative factors for pain flare-ups through remotely reported outcomes. The discrete clinical data and patient-reported outcomes enable providers to improve clinical decision making, while reducing liability and billing concerns with payors. These algorithms help providers respond more efficiently to new data so their patients will have fewer complications or side effects.

Click here to learn more about cliexa’s Digital Solutions for Healthcare.

cliexa PTSI Press Release

We are proud to announce that we have officially joined forces with Preventative Technology Solutions, who will now become apart of the cliexa family.

Here is the link to the press release about the acquisition: //www.pr.com/press-release/768313

 

Digital health benefits

2018 has seen a significant boom in the application of technology in digital health innovation, which are poised to disrupt the healthcare industry. Innovations have included advances in mobile health (mHealth), health information technology (IT), as well as wearable and Internet-of-Things (IoT) devices.

cliexa has identified six specific areas of medicine already reaping the benefits of digital health innovation:

1. Rheumatology

Disease Activity Scoring (DAS) metrics remotely collected by cliexa from patients are used by physicians in their offices when assessing the severity of rheumatoid arthritis through a Q & A approach. cliexa empowers patients with the ability to communicate their patient-reported outcomes to their physicians at the touch of a finger, on their own mobile devices, providing physicians with instantly-scored clinically-validated assessments. The application of cliexa innovations in rheumatology drastically increases the efficiency and quality-of-care for both patients and their providers.

Check out the cliexa mobile platform for Rheumatoid Arthritis, cliexa-RA: //www.cliexa.com/cliexamobile/rheumatoid-arthritis/

2. Pain Management, Primary Care, & Integrative Medicine

Chronic pain, affecting over 10% of American adults, is a leading cause of opiate abuse. Managing and overcoming chronic pain is a complex obstacle for many healthcare providers. With the increased shift away from the prescribing of opioids in the treatment of chronic pain, cliexa enables providers to remotely monitors opioid-prescribed patients while empowering them to relay their patient-reported outcomes and track their mental health conditions in association with their chronic pain, while catering specifically towards the individual needs of each patient-provider relationship.

Check out the cliexa mobile platform for Pain Management, cliexa-EASE: //www.cliexa.com/cliexamobile/pain-management/

3. Behavioral Health & Addiction Treatment

Though struggles with addiction are becoming increasingly more prevalent in society, the present methods of addiction treatment are limited. Through innovations in health technologies, patients and providers are shifting towards new ways of treating addiction. The monitoring of patients in real-time is essential for positive treatment outcomes for both patients and their providers. By leveraging patient-reported data, patients adhere to their treatment plans and overcome addiction as a disease, rather than as a fault.

Check out the cliexa mobile platform for Behavioral Health, cliexa-SENSE: //www.cliexa.com/cliexamobile/behavioral-health/

4. Digestive Health

Through cliexa innovations, providers better manage chronic gastrointestinal diseases, such as inflammatory bowel disease or ulcerative colitis, using specifically-designed, highly-structured treatment plans that leverage disease activity scoring models taken from qualitative patient responses to assessments which quantify and track symptoms over long periods of time.

Check out the cliexa mobile platform for Digestive Health, cliexa-IBD: //www.cliexa.com/cliexamobile/inflammatory-bowel-disease/

5. Respiratory Care

cliexa enables providers to qualitatively track chronic diseases of the respiratory system, like chronic obstructive pulmonary disease (COPD), through remote patient-reported outcomes. The ability to structure individualized and specialized care leads to improved patient-provider experiences.

Check out the cliexa mobile platform for Respiratory Care, cliexa-COPD: //www.cliexa.com/cliexamobile/chronic-obstructive-pulmonary-disease/

6. Pediatric Care

cliexa health technology drives innovations in mental health resiliency in adolescents, a hot topic in today’s health community. cliexa’s clinically validated medical assessment applications, coupled with its mHealth prevention services, help providers identify and reduce risk behaviors in adolescents and young adults. cliexa’s mobile patient-engagement applications equip providers with the tools adolescents use to overcome anxiety and depression, increasing the overall quality-of-care for both patients and providers.

Check out the cliexa mobile platform for Pediatric Care, cliexa-OPTIONS: //www.cliexa.com/cliexamobile/adolescent-resiliency/

cliexaRA Press Release

cliexa® partners with the Colorado Arthritis Center to identify how screening and monitoring of Rheumatoid Arthritis patients through a customized electronic platform, cliexa-RA, impacts clinical efficiency.

See the full press release from PR.com: https://www.pr.com/press-release/765307

Download the Case Study here: https://www.cliexa.com/cliexa-ra-case-study/

Learn more about cliexa-RA: https://www.cliexa.com/cliexamobile/rheumatoid-arthritis/